Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4833 - 4840 of 11616 results
MLS Weekly Preview: Congress Keeping its Focus on Drug Costs
April 8, 2019| Blog| Viewpoint
What is a “Reasoned” Arbitration Award?
April 8, 2019| Blog| Viewpoint
How to Value a Solar Development Pipeline (Part 4 of 4)
April 8, 2019| Blog| Viewpoint
USCIS Reaches Statutory Limit of H-1B Cap Cases for Fiscal Year 2020
April 8, 2019| Alert| Viewpoint
What the DACA Repeal Means for Students
April 7, 2019| News
How to Value a Solar Development Pipeline (Part 3 of 4)
April 5, 2019| Blog| Viewpoint
Interim Guidance Under §4960: Excise Taxes and Parachute Payments
April 5, 2019| News
Interim Guidance Under §4960: Excise Taxes and Parachute Payments
April 5, 2019| News
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.